Arbutus Biopharma Corp Receivables Turnover Ratio (ABUS), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Arbutus Biopharma Corp  (NASDAQ: ABUS)
 

Arbutus Biopharma Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Arbutus Biopharma Corp's ability to collect accounts receivable sequentially worsen to 2.35, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Arbutus Biopharma's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 155 days, from 63 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 308 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1004 to 2320.

What is Receivable Turnover Ratio?
What is Arbutus Biopharma Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABUS Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change 15879.82 % 9191.04 % -84.79 % -36.84 % -45.57 %
Y / Y Revenue Change -90.56 % 10054.54 % -33.23 % -60.49 % 522.19 %
Receivable Turnover Ratio (TTM) 2.35 5.84 14.04 10.28 9.65
ABUS's Total Ranking # 2320 # 1004 # 1220 # 1322 # 3266
Accounts Receivable average collection period days 156 62 26 36 38
Seq. Receivable Change 40.01 % 42700.73 % -75.1 % 7.11 % -18.6 %
Seq. Revenue Change -99.43 % 16943.39 % 98.68 % -95.07 % 508.79 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 89
Healthcare Sector # 309
Overall Market # 2320

Receivable Turnover Ratio Statistics
High Average Low
26.09 8.03 0.53
(Sep 30 2022)   (Mar 31 2017)





ABUS Company Profile • Back to ABUS Efficiency Comparisons • Compare ABUS Receivables Turnover Ratio to its Competitors

Financial Statements
Arbutus Biopharma's Accounts Receivable $ 180 Millions Visit ABUS's Balance sheet
Arbutus Biopharma's Sales TTM $ 182 Millions Visit ABUS's Income Statement
Sources of ABUS's Revenues Visit ABUS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ABUS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ABUS's Growth Rates ABUS's Roa ABUS's Inventory Turnover Ratio ABUS's Dividend Comparisons
ABUS's Profitability Ratios ABUS's Roi ABUS's Asset Turnover Ratio ABUS's Dividend Growth
ABUS's Valuation Ratios ABUS's Roe ABUS's Financial Strength Ratios ABUS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Harrow Inc   2.69 $ 274.724  Millions$ 102.078  Millions
Electromed Inc   2.64 $ 72.076  Millions$ 27.317  Millions
Onemednet Corporation  2.61 $ 1.590  Millions$ 0.609  Millions
American Shared Hospital Services  2.58 $ 30.210  Millions$ 11.732  Millions
Cardiff Oncology Inc   2.49 $ 0.508  Millions$ 0.204  Millions
Cumberland Pharmaceuticals Inc   2.27 $ 31.269  Millions$ 13.764  Millions
Co diagnostics Inc   2.14 $ 0.721  Millions$ 0.337  Millions
60 Degrees Pharmaceuticals Inc   2.13 $ 1.111  Millions$ 0.522  Millions
Cardio Diagnostics Holdings Inc   2.10 $ 0.014  Millions$ 0.007  Millions
Scilex Holding Company  1.93 $ 31.608  Millions$ 16.396  Millions
Heron Therapeutics Inc   1.76 $ 151.507  Millions$ 85.975  Millions
Bio Green Med Solution Inc   1.75 $ 1.861  Millions$ 1.061  Millions
Biocorrx Inc   1.67 $ 0.787  Millions$ 0.471  Millions
Prophase Labs Inc   1.59 $ 3.150  Millions$ 1.977  Millions
Amarin Corp Plcuk  1.49 $ 186.480  Millions$ 125.559  Millions
Skinvisible Inc   1.45 $ 0.020  Millions$ 0.014  Millions
Lightwave Logic Inc   1.40 $ 0.250  Millions$ 0.178  Millions
Clene Inc   1.15 $ 0.197  Millions$ 0.171  Millions
Instil Bio Inc   1.15 $ 8.968  Millions$ 7.822  Millions
Scienture Holdings Inc   1.15 $ 0.821  Millions$ 0.717  Millions
Regen Biopharma Inc   0.99 $ 0.237  Millions$ 0.239  Millions
Prokidney Corp   0.75 $ 0.818  Millions$ 1.088  Millions

Date modified: 2026-09-03T16:30:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.